Correspondingly, Spautin-1 treatment in DLBCL cells enhanced ROS, LPO, and suppressed GSH level in synergy with Dox and CTX (Fig. 5H, I, Supplementary Fig. 5C, D, Supplementary Fig. 6A, B). Here, LPO is linked to diffuse large B-cell lymphoma.